request for proposals translational funding – 2017-2018
background and description of opportunity
the canadian glycomics network (glyconet) is a network of centres of excellence that focuses on the role of glycans (carbohydrates) in health. areas of focus are therapeutic proteins & vaccines, antimicrobials and chronic disease, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. ad-ditional information about network research can be found at www.glyconet.ca.
a key goal of glyconet is the translation of research advances into novel products for treating disease. accordingly this request for proposals seeks to fund more mature projects needing network support to de-risk and advance them to a state at which translation is possible.
requirements
projects should:
• be aligned with one of the glyconet research themes (see glyconet.ca).
• be multidisciplinary and involve at least two research groups.
• must have an articulated ip and patentability strategy.
• be accompanied by a commercialisation plan provided by the technology transfer office of the project leader’s institution.
• have a clear endpoint, successful completion of which would attract a potential partner.
• ability to demonstrate partner support is preferred.
funding available
glyconet has set aside up to $600,000 for this competition. proposals may request up to $200,000 in funding. it is anticipated that projects will be completed within 12 months; justification should be provided for longer funding periods. continued funding for projects past the 12-month period will be considered on a case-by-case basis in consultation with the commercialization committee.
eligibility
this opportunity is open only to individuals eligible to hold tri-council funds; i.e., the canadian institutes of health research (cihr), the natural sciences and engineering research council of canada (nserc) or the social sci-ences and humanities research council of canada (sshrc).
an individual may serve as the project leader on only one translational funding application and may not be in-volved in more than two translational funding applications. simultaneous application for phase i and phase ii funding for the same project is not allowed.